8er6 - Revision history

OCA at 10:23, 25 October 2023

2023-10-25T10:23:29Z

←Older revision		Revision as of 10:23, 25 October 2023
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[8er6]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8ER6 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8ER6 FirstGlance]. <br>		<table><tr><td colspan='2'>[[8er6]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8ER6 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8ER6 FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=XYU:(3S,5R,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,30R,34aS)-5,9,27-trihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-5,6,9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-octadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,11,28,29(4H,31H)-tetrone'>XYU</scene></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.81Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=XYU:(3S,5R,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,30R,34aS)-5,9,27-trihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-5,6,9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-octadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,11,28,29(4H,31H)-tetrone'>XYU</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8er6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8er6 OCA], [https://pdbe.org/8er6 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8er6 RCSB], [https://www.ebi.ac.uk/pdbsum/8er6 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8er6 ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8er6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8er6 OCA], [https://pdbe.org/8er6 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8er6 RCSB], [https://www.ebi.ac.uk/pdbsum/8er6 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8er6 ProSAT]</span></td></tr>
	</table>		</table>
Line 18:		Line 19:
	</div>		</div>
	<div class="pdbe-citations 8er6" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 8er6" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[FKBP 3D structures\|FKBP 3D structures]]
	== References ==		== References ==
	<references/>		<references/>

OCA at 09:10, 28 December 2022

2022-12-28T09:10:49Z

←Older revision		Revision as of 09:10, 28 December 2022
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 8er6 is ~~ON HOLD~~	+	==FKBP12-FRB in Complex with Compound 11==
		+	<StructureSection load='8er6' size='340' side='right'caption='[[8er6]], [[Resolution\|resolution]] 2.81Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[8er6]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8ER6 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8ER6 FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=XYU:(3S,5R,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,30R,34aS)-5,9,27-trihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-5,6,9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-octadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,11,28,29(4H,31H)-tetrone'>XYU</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8er6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8er6 OCA], [https://pdbe.org/8er6 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8er6 RCSB], [https://www.ebi.ac.uk/pdbsum/8er6 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8er6 ProSAT]</span></td></tr>
		+	</table>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/FKB1A_HUMAN FKB1A_HUMAN] Keeps in an inactive conformation TGFBR1, the TGF-beta type I serine/threonine kinase receptor, preventing TGF-beta receptor activation in absence of ligand. Recruites SMAD7 to ACVR1B which prevents the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. May modulate the RYR1 calcium channel activity. PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides.<ref>PMID:9233797</ref> <ref>PMID:16720724</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Hyperactivation of mTOR kinase by mutations in the PI3K/mTOR pathway or by crosstalk with other mutant cancer drivers, such as RAS, is a feature of many tumors. Multiple allosteric inhibitors of mTORC1 and orthosteric dual inhibitors of mTORC1 and mTORC2 have been developed as anticancer drugs, but their clinical utility has been limited. To address these limitations, we have developed a novel class of "bi-steric inhibitors" that interact with both the orthosteric and the allosteric binding sites in order to deepen the inhibition of mTORC1 while also preserving selectivity for mTORC1 over mTORC2. In this report, we describe the discovery and preclinical profile of the development candidate RMC-5552 and the in vivo preclinical tool compound RMC-6272. We also present evidence that selective inhibition of mTORC1 in combination with covalent inhibition of KRAS(G12C) shows increased antitumor activity in a preclinical model of KRAS(G12C) mutant NSCLC that exhibits resistance to KRAS(G12C) inhibitor monotherapy.

-	~~Authors: Tomlinson~~, ~~A.C~~.A., ~~Yano~~, J.K.	+	Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated Tumors.,Burnett GL, Yang YC, Aggen JB, Pitzen J, Gliedt MK, Semko CM, Marquez A, Evans JW, Wang G, Won WS, Tomlinson ACA, Kiss G, Tzitzilonis C, Thottumkara AP, Cregg J, Mellem KT, Choi JS, Lee JC, Zhao Y, Lee BJ, Meyerowitz JG, Knox JE, Jiang J, Wang Z, Wildes D, Wang Z, Singh M, Smith JAM, Gill AL J Med Chem. 2022 Dec 19. doi: 10.1021/acs.jmedchem.2c01658. PMID:36533617<ref>PMID:36533617</ref>

-	~~Description: FKBP12~~-~~FRB in Complex with Compound 11~~	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	[[Category: ~~Unreleased~~ Structures]]	+	</div>
-	[[Category: Tomlinson~~, A.C.A~~]]	+	<div class="pdbe-citations 8er6" style="background-color:#fffaf0;"></div>
-	[[Category: Yano~~, J.K~~]]	+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Homo sapiens]]
		+	[[Category: Large Structures]]
		+	[[Category: Tomlinson ACA]]
		+	[[Category: Yano JK]]

OCA at 06:22, 21 December 2022

2022-12-21T06:22:16Z

←Older revision		Revision as of 06:22, 21 December 2022
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 8er6 is ON HOLD ~~until sometime in the future~~	+	The entry 8er6 is ON HOLD

	Authors: Tomlinson, A.C.A., Yano, J.K.		Authors: Tomlinson, A.C.A., Yano, J.K.

OCA at 04:00, 26 October 2022

2022-10-26T04:00:28Z

←Older revision		Revision as of 04:00, 26 October 2022
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 8er6 is ON HOLD	+	The entry 8er6 is ON HOLD until sometime in the future

	Authors: Tomlinson, A.C.A., Yano, J.K.		Authors: Tomlinson, A.C.A., Yano, J.K.

OCA: Protected "8er6" [edit=sysop:move=sysop]

2022-10-19T17:28:13Z

Protected "8er6" [edit=sysop:move=sysop]

←Older revision

Revision as of 17:28, 19 October 2022

OCA: New page: '''Unreleased structure''' The entry 8er6 is ON HOLD Authors: Tomlinson, A.C.A., Yano, J.K. Description: FKBP12-FRB in Complex with Compound 11 Category: Unreleased Structures [[Ca...

2022-10-19T17:28:10Z

New page: '''Unreleased structure''' The entry 8er6 is ON HOLD Authors: Tomlinson, A.C.A., Yano, J.K. Description: FKBP12-FRB in Complex with Compound 11 Category: Unreleased Structures [[Ca...

New page

'''Unreleased structure'''

The entry 8er6 is ON HOLD

Authors: Tomlinson, A.C.A., Yano, J.K.

Description: FKBP12-FRB in Complex with Compound 11
[[Category: Unreleased Structures]]
[[Category: Tomlinson, A.C.A]]
[[Category: Yano, J.K]]